{"entities":{"Q9899":{"pageid":14060,"ns":120,"title":"Item:Q9899","lastrevid":205817,"modified":"2020-05-21T15:47:44Z","type":"item","id":"Q9899","labels":{"en":{"language":"en","value":"Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9899$7E809752-1EF2-463C-93A9-CDEA1586C79E","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9899$1CF14E9B-78B2-4F03-A322-9BD39CCDB79D","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Meindl-Beinker NM","type":"string"},"datatype":"string"},"type":"statement","id":"Q9899$00934F0B-49F6-482E-95BC-393468EB81D1","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1186/s12885-019-5446-2","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9899$4ABDE283-EED8-45D0-9EDD-507B3345F231","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"30871493","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9899$9DC20E1C-1C34-49D6-9E7B-23D6EC209527","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2019-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9899$8FF02588-9661-4804-823B-4D9366EF56D1","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"BMC Cancer","type":"string"},"datatype":"string"},"type":"statement","id":"Q9899$A1E810C6-F671-4BEA-AE03-E67BF5DEE59A","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"19","type":"string"},"datatype":"string"},"type":"statement","id":"Q9899$438FCBED-325F-4969-9B8A-B62818A57C9E","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9899$BB0C2198-14D2-4AC8-A586-C81119C3C4FC","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"231-","type":"string"},"datatype":"string"},"type":"statement","id":"Q9899$FF558D21-6682-4BDD-91C6-560329ABA70F","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Meindl-Beinker_NM,_et_al._BMC_Cancer_(2019)_cited_as_Ref_636_in_DOI:_10.1038/s41392-020-0110-5"}}}}}